Ekaterina Rishatovna Yakupova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ekaterina Rishatovna Yakupova has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Timur Bulatovich Minasov
Bashkir State Medical University
19 shared publications - Ruslan Faritovich Khairutdinov
Chelyabinsk Regional Clinical Hospital
12 shared publications - Elvina Ilshatovna Mukhametzyanova
Bashkir State Medical University
7 shared publications - Radmir Amirovich Saubanov
Bashkir State Medical University
6 shared publications - Akop Ovikovich Ginoyan
Bashkir State Medical University
5 shared publications - A. A. Faizullin4 shared publications
Latest Publications
- 29 September 2026
- Published by PANORAMA Publishing House in Vrač Skoroj Pomoŝi (Emergency Doctor)
- No. 9,p. 37-49
Artificial intelligence in medicine. History and prospects
Today, artificial intelligence (AI) is viewed as a key driver of digital transformation in healthcare. However, the journey toward modern diagnostic systems and personalized medicine has spanned more than half a century and involved several stages, from theoretical concepts to full-scale clinical integration. Currently, AI is permeating all areas of medicine: from diagnostic imaging to surgery, from epidemiology to nutrition, and from genomics to the assessment of chronic disease risks [29]. Traumatology and orthopedics occupy a special place in this context, as AI technologies open up new possibilities for understanding tissue morphogenesis, planning surgical interventions, predicting outcomes, and preventing complications. In this article, we trace the evolution of medical AI, from the inception of the «thinking machine» concept to modern deep learning algorithms, and examine practical examples of AI applications in orthopedics and related fields, from the morphogenesis of knee ligaments [27] and the choice of osteosynthesis method for tibial fractures [18] to the development of validated osteoarthritis risk scales [28], the stratification of decompensated osteoarthritis based on phenotyping and endotyping [20], and the prevention of osteoporotic fractures using internal load-shunting techniques [19, 11].
- 29 September 2026
- Published by PANORAMA Publishing House in Vrač Skoroj Pomoŝi (Emergency Doctor)
- No. 9,p. 37-49
Artificial intelligence in medicine. History and prospects
Today, artificial intelligence (AI) is viewed as a key driver of digital transformation in healthcare. However, the journey toward modern diagnostic systems and personalized medicine has spanned more than half a century and involved several stages, from theoretical concepts to full-scale clinical integration. Currently, AI is permeating all areas of medicine: from diagnostic imaging to surgery, from epidemiology to nutrition, and from genomics to the assessment of chronic disease risks [29]. Traumatology and orthopedics occupy a special place in this context, as AI technologies open up new possibilities for understanding tissue morphogenesis, planning surgical interventions, predicting outcomes, and preventing complications. In this article, we trace the evolution of medical AI, from the inception of the «thinking machine» concept to modern deep learning algorithms, and examine practical examples of AI applications in orthopedics and related fields, from the morphogenesis of knee ligaments [27] and the choice of osteosynthesis method for tibial fractures [18] to the development of validated osteoarthritis risk scales [28], the stratification of decompensated osteoarthritis based on phenotyping and endotyping [20], and the prevention of osteoporotic fractures using internal load-shunting techniques [19, 11].
- 20 July 2026
- Published by PANORAMA Publishing House
- No. 7,p. 25-34
Workspace organization as a factor in office worker productivity
Modern office work entails prolonged physical inactivity, which can lead to reduced productivity, fatigue, and even pain syndromes affecting various parts of the musculoskeletal system. A review of the literature reveals a lack of data regarding the comprehensive assessment of how workplace ergonomic factors influence work performance. Most studies focus either on specific musculoskeletal symptoms or on isolated aspects of working posture and workplace organization. An additional challenge lies in the choice of assessment tools: specialized scales for evaluating cognitive functions and attention are often cumbersome, require separate testing, and are primarily used in neuropsychological practice. This limits their application in studies of everyday office activities. The aim of the study was to evaluate the impact of an ergonomic office chair with armrests and a headrest on productivity, concentration, comfort, fatigue, and pain severity among office workers.
- 20 July 2026
- Published by PANORAMA Publishing House
- No. 7,p. 25-34
Workspace organization as a factor in office worker productivity
Modern office work entails prolonged physical inactivity, which can lead to reduced productivity, fatigue, and even pain syndromes affecting various parts of the musculoskeletal system. A review of the literature reveals a lack of data regarding the comprehensive assessment of how workplace ergonomic factors influence work performance. Most studies focus either on specific musculoskeletal symptoms or on isolated aspects of working posture and workplace organization. An additional challenge lies in the choice of assessment tools: specialized scales for evaluating cognitive functions and attention are often cumbersome, require separate testing, and are primarily used in neuropsychological practice. This limits their application in studies of everyday office activities. The aim of the study was to evaluate the impact of an ergonomic office chair with armrests and a headrest on productivity, concentration, comfort, fatigue, and pain severity among office workers.
- 23 March 2026
- Published by PANORAMA Publishing House in Vrač Skoroj Pomoŝi (Emergency Doctor)
- No. 3,p. 22-38
Gut microbiota and osteoarthritis
The article presents the results of a study on the efficacy of the probiotic strain Streptococcus thermophilus TCI633 as part of the drug «Kondraktiv B» in the complex therapy of knee joint osteoarthritis (OA). It is shown that a three-month course of probiotic intake leads to a statistically significant improvement in clinical and functional status: the Knee Society Score (KSS) increased by 19.9% (p < 0.001) in the study group compared to 6.0% in the control group (p > 0.05). The therapy was accompanied by a significant reduction in systemic inflammation markers: C-reactive protein levels decreased by 37.1% and the erythrocyte sedimentation rate by 32.9% (p < 0.001). The obtained data are discussed within the context of the pathogenic role of the «gut-joint» axis. The supposed mechanisms of action of the strain, including strengthening of the intestinal barrier, reduction of endotoxemia, and immune response modulation, are considered. The results justify the inclusion of targeted probiotic correction in the strategy of pathogenetic OA treatment aimed at controlling systemic inflammation. The need for further studies to determine optimal dosing regimens and responsive disease phenotypes is highlighted.
- 23 March 2026
- Published by PANORAMA Publishing House in Vrač Skoroj Pomoŝi (Emergency Doctor)
- No. 3,p. 22-38
Gut microbiota and osteoarthritis
The article presents the results of a study on the efficacy of the probiotic strain Streptococcus thermophilus TCI633 as part of the drug «Kondraktiv B» in the complex therapy of knee joint osteoarthritis (OA). It is shown that a three-month course of probiotic intake leads to a statistically significant improvement in clinical and functional status: the Knee Society Score (KSS) increased by 19.9% (p < 0.001) in the study group compared to 6.0% in the control group (p > 0.05). The therapy was accompanied by a significant reduction in systemic inflammation markers: C-reactive protein levels decreased by 37.1% and the erythrocyte sedimentation rate by 32.9% (p < 0.001). The obtained data are discussed within the context of the pathogenic role of the «gut-joint» axis. The supposed mechanisms of action of the strain, including strengthening of the intestinal barrier, reduction of endotoxemia, and immune response modulation, are considered. The results justify the inclusion of targeted probiotic correction in the strategy of pathogenetic OA treatment aimed at controlling systemic inflammation. The need for further studies to determine optimal dosing regimens and responsive disease phenotypes is highlighted.
- Open Access
- 10 February 2026
- Published by ECO-Vector LLC (Publications) in N.N. Priorov Journal of Traumatology and Orthopedics
- Vol. 33 (1) , 202-219
Prospects for the use of structure-modifying drugs and adjuvant therapies for osteoarthritis before and after joint arthroplasty: a review
This review addresses practical issues of rational pharmacotherapy and adjuvant treatment of osteoarthritis before and after total knee arthroplasty (TKA). The review analyzes the mechanisms underlying complications associated with total knee arthroplasty, the role of comorbid conditions in the development of osteoarthritis and TKA-related complications, and current approaches to phenotyping and endotyping of osteoarthritis for predicting postoperative complications and selecting optimal strategies for preoperative management and postoperative rehabilitation. Particular attention is paid to the mechanisms of action of components and to the personalized selection of disease-modifying and adjuvant therapies at different stages of patient management before and after total knee arthroplasty. The review describes recommended dosing regimens, maximum daily doses, and maximum durations of use for selected structure-modifying drugs and adjuvant therapies for osteoarthritis before and after total knee arthroplasty, based on data from clinical studies and in accordance with instructions for medical use. One of the key aspects of a multimodal, staged approach to managing patients with knee osteoarthritis before and after total knee arthroplasty is the personalized selection of structure-modifying drugs and adjuvant therapies, taking into account individual patient characteristics, including age, comorbidities, and drug tolerability. Standardization of pain assessment, evaluation of biomarkers of structural modification of articular cartilage, and a personalized approach to drug selection are essential for achieving effective and safe management of patients with knee osteoarthritis undergoing total knee arthroplasty, reducing the risk of adverse drug reactions, and improving treatment satisfaction and quality of life after surgical intervention.
- 10 February 2026
- Published by ECO-Vector LLC (Publications) in N.N. Priorov Journal of Traumatology and Orthopedics
- Vol. 33 (1) , 202-219
Open AccessProspects for the use of structure-modifying drugs and adjuvant therapies for osteoarthritis before and after joint arthroplasty: a review
This review addresses practical issues of rational pharmacotherapy and adjuvant treatment of osteoarthritis before and after total knee arthroplasty (TKA). The review analyzes the mechanisms underlying complications associated with total knee arthroplasty, the role of comorbid conditions in the development of osteoarthritis and TKA-related complications, and current approaches to phenotyping and endotyping of osteoarthritis for predicting postoperative complications and selecting optimal strategies for preoperative management and postoperative rehabilitation. Particular attention is paid to the mechanisms of action of components and to the personalized selection of disease-modifying and adjuvant therapies at different stages of patient management before and after total knee arthroplasty. The review describes recommended dosing regimens, maximum daily doses, and maximum durations of use for selected structure-modifying drugs and adjuvant therapies for osteoarthritis before and after total knee arthroplasty, based on data from clinical studies and in accordance with instructions for medical use. One of the key aspects of a multimodal, staged approach to managing patients with knee osteoarthritis before and after total knee arthroplasty is the personalized selection of structure-modifying drugs and adjuvant therapies, taking into account individual patient characteristics, including age, comorbidities, and drug tolerability. Standardization of pain assessment, evaluation of biomarkers of structural modification of articular cartilage, and a personalized approach to drug selection are essential for achieving effective and safe management of patients with knee osteoarthritis undergoing total knee arthroplasty, reducing the risk of adverse drug reactions, and improving treatment satisfaction and quality of life after surgical intervention.
- 22 September 2024
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 5,p. 5-14
Features of mineral metabolism in cholelithiasis
The article presents modern data on the study of cholelithiasis. Information on the etiology and pathogenetic mechanisms of the disease has been selected. A clinical case is described. The results of the analysis of age and gender groups in cholelithiasis are presented, and the leading treatment tactics of the adult population in Ufa, Republic of Bashkortostan, are identified. It is shown that the tactics of administration is determined individually depending on the patient’s concomitant diseases and the course of the disease.
- 22 September 2024
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 5,p. 5-14
Features of mineral metabolism in cholelithiasis
The article presents modern data on the study of cholelithiasis. Information on the etiology and pathogenetic mechanisms of the disease has been selected. A clinical case is described. The results of the analysis of age and gender groups in cholelithiasis are presented, and the leading treatment tactics of the adult population in Ufa, Republic of Bashkortostan, are identified. It is shown that the tactics of administration is determined individually depending on the patient’s concomitant diseases and the course of the disease.
- 30 June 2024
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 3,p. 5-15
Possibilities of using short stems of hip endoprosthesis: meta-analysis
Short femoral stems of the hip endoprosthesis with femoral neck preservation facilitate the restoration of the anatomy of the proximal femur and the physiological biomechanics of the hip joint. The design of the stem is of particular interest as it allows for the creation of a hip joint with higher functional characteristics and increased service life of implants that are easier to replace. Neck-sparing short femoral stems achieve excellent early and mid-term results in both clinical and radiographic parameters that are functionally equivalent to conventional femoral stems. To date, the results of this meta-analysis indicate that neck-sparing stems may provide better bone mineral density maintenance than their conventional counterparts, in addition to lower incidence of hip pain.
- 30 June 2024
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 3,p. 5-15
Possibilities of using short stems of hip endoprosthesis: meta-analysis
Short femoral stems of the hip endoprosthesis with femoral neck preservation facilitate the restoration of the anatomy of the proximal femur and the physiological biomechanics of the hip joint. The design of the stem is of particular interest as it allows for the creation of a hip joint with higher functional characteristics and increased service life of implants that are easier to replace. Neck-sparing short femoral stems achieve excellent early and mid-term results in both clinical and radiographic parameters that are functionally equivalent to conventional femoral stems. To date, the results of this meta-analysis indicate that neck-sparing stems may provide better bone mineral density maintenance than their conventional counterparts, in addition to lower incidence of hip pain.
- 20 April 2024
- Published by PANORAMA Publishing House in Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
- No. 4,p. 5-12
Sarcopenia and osteoarthritis: meta-analysis
- 20 April 2024
- Published by PANORAMA Publishing House in Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
- No. 4,p. 5-12
Sarcopenia and osteoarthritis: meta-analysis
- 20 March 2024
- Published by PANORAMA Publishing House in Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
- No. 3,p. 5-17
Efficacy of mineral metabolism correction in orthopedic patients
- 20 March 2024
- Published by PANORAMA Publishing House in Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
- No. 3,p. 5-17
Efficacy of mineral metabolism correction in orthopedic patients
- 2 November 2023
- Published by PANORAMA Publishing House
- No. 10,p. 17-25
Sarcopenia and osteoarthritis of the hip joint
Sarcopenia is a pathology characterized by a decrease in the mass and strength of muscle tissue in most cases in older people. Osteoarthritis is also a common disease in elderly patients and is characterized by irreversible destructive and dystrophic damage to the joints. Decompensated stages of osteoarthritis of the hip joint often require surgical treatment. It has been noted that the majority of patients requiring total hip replacement for osteoarthritis also suffer from sarcopenia. Considering the clinical and biomechanical role of the muscular system together with the musculoskeletal system, sarcopenia can affect the recovery process of patients after surgery and the success of the operation itself. However, scientific research on the influence of sarcopenia on the results of total hip arthroplasty is insufficient. This article presents the results of a study of the negative impact of sarcopenia in patients who underwent total hip replacement. The study identified sarcopenia as an important risk factor that orthopedic traumatologists should consider when surgically treating patients with stages 3–4 osteoar thritis.
- 2 November 2023
- Published by PANORAMA Publishing House
- No. 10,p. 17-25
Sarcopenia and osteoarthritis of the hip joint
Sarcopenia is a pathology characterized by a decrease in the mass and strength of muscle tissue in most cases in older people. Osteoarthritis is also a common disease in elderly patients and is characterized by irreversible destructive and dystrophic damage to the joints. Decompensated stages of osteoarthritis of the hip joint often require surgical treatment. It has been noted that the majority of patients requiring total hip replacement for osteoarthritis also suffer from sarcopenia. Considering the clinical and biomechanical role of the muscular system together with the musculoskeletal system, sarcopenia can affect the recovery process of patients after surgery and the success of the operation itself. However, scientific research on the influence of sarcopenia on the results of total hip arthroplasty is insufficient. This article presents the results of a study of the negative impact of sarcopenia in patients who underwent total hip replacement. The study identified sarcopenia as an important risk factor that orthopedic traumatologists should consider when surgically treating patients with stages 3–4 osteoar thritis.
- 20 November 2022
- Published by PANORAMA Publishing House
- No. 11,p. 21-31
Possibilities of structure modifying therapy of subcompensated gonarthrosis
This study shows that a combined treatment regimen consisting of a NSAID group drug and a slow-acting chondroprotective agent has a positive effect in the therapy of subcompensated osteoarthritis of the knee joint. Diacerein has an anti-inflammatory effect and inhibits the activity of interleukin-1, interleukin-6, and TNF-alpha, as well as collagenase and elastase, which destroy the hyaline cartilage. However, the effect of the drug does not occur immediately, which justifies its combination with NSAIDs.
- 20 November 2022
- Published by PANORAMA Publishing House
- No. 11,p. 21-31
Possibilities of structure modifying therapy of subcompensated gonarthrosis
This study shows that a combined treatment regimen consisting of a NSAID group drug and a slow-acting chondroprotective agent has a positive effect in the therapy of subcompensated osteoarthritis of the knee joint. Diacerein has an anti-inflammatory effect and inhibits the activity of interleukin-1, interleukin-6, and TNF-alpha, as well as collagenase and elastase, which destroy the hyaline cartilage. However, the effect of the drug does not occur immediately, which justifies its combination with NSAIDs.